UNITED STATES
             SECURITIES  AND  EXCHANGE  COMMISSION
                   Washington,  D.C.  20549
                   
                        FORM 10-QSB
                             
[x]  Quarterly report pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934   For the quarterly
Period Ended March 31, 1998

                            or
                             
[  ] Transition Report Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934   For the transition
period from _____________to __________

Commission file number 0-19685

                  METROVISION OF NORTH AMERICA, INC.
(Exact name of registrant as specified in its charter)

New York
(State of other jurisdiction of incorporation or
organization) 16-1276525
(IRS Employer Identification No)

75 South Church Street Pittsfield, Massachusetts   01201
(Address of principal executive offices)       (Zip Code)

(413) 448-2111
(Registrant's telephone number, including area code)

Not Applicable
(Former name, former address and former fiscal year, if
changed since last report)

Indicate  by check mark whether the registrant (1) has filed
all reports  required  to be filed by Section  13  or  15(d)
of  the Securities   Exchange Act of 1934 during the
preceding 12  months (or for such shorter period that the
registrant was required to file such reports), and (2) has
been subject  to such filing requirements for the past 90
days.  Yes X  No




Applicable Only to Corporate Issuers

Indicate the number of shares outstanding of each of the
issuer's classes of common equity, as of the latest practical
date.

Common Stock, $.001 Par Value - 5,574,275 shares as of May
15, 1998.

Transitional Small Business Issuer Format (Check one)
Yes        No  X

METROVISION OF NORTH AMERICA, INC.

INDEX
                                                   Page #
Part I. Financial Information
Item 1.Interim Condensed Consolidated Financial Statements
       (Unaudited)

Interim condensed consolidated balance sheets:
     December 31, 1997
     March 31, 1998                                   3

Interim condensed consolidated statements of operations:
     Three months ended March 31, 1997 and 1998       5

Interim condensed consolidated statements of cash flows:
     Three months ended March 31, 1997 and 1998       6
Item 2.Management's Discussion and Analysis of Financial

       Condition and Results of Operations            9

Part II.  Other Information

Item 6.                                               13

Signatures                                            14

               PART I - FINANCIAL INFORMATION

             METROVISION OF NORTH AMERICA, INC.

        INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS
                              
                              
                              
                              
               ASSETS               December  31,   March 31,
                                        1997          1998
                                                   Unaudited)

CURRENT ASSETS:
 Cash and cash equivalents         $  11,956         $15,764
                              
           Total current assets       11,956          15,764


OTHER ASSETS:
Investment in York Hannover
    Partnership                    1,269,195       1,371,654
           Total other assets      1,269,195       1,371,654

           Total assets           $1,281,151      $1,387,418







The accompanying notes to the interim condensed consolidated
financial statements are an integral part of these
consolidated financial statements.


             METROVISION OF NORTH AMERICA, INC.
                              
                              
                 CONSOLIDATED BALANCE SHEETS
                              
                         (Continued)
                              
LIABILITIES AND STOCKHOLDERS' DEFICIT   December 31 March 31
                                            1998      1998
CURRENT LIABILITIES:
Due to related parties                  $ 596,957   $571,957
Accrued expenses                          297,765    388,567
Notes payable                           1,950,000  1,950,000
Net liability of discontinued operations  893,231    853,539
     Total current liabilities          3,737,953  3,764,063
STOCKHOLDERS' DEFICIT:
Preferred stock, $.001 par value, 1,280,000
  shares authorized, no shares outstanding      --        --
Cumulative Preferred stock, 5% Series A
  $.001 par value, 720,000 shares authorized, $5.56 per share
  redemption value and liquidation value, 648,535
shares issued and outstanding                   --          -
-
Common stock, Class A                        5,574     5,574
Capital (deficit) in excess of par value 1,077,050 1,077,050
Accumulated deficit                    (3,540,075)(3,459,918)
     Total stockholders' deficit       (2,456,802)(2,376,645)
     Total liabilities and stockholders'
         deficit                        $1,281,151 $1,387,418
The accompanying notes to the interim condensed consolidated
financial statements are an integral part of these
consolidated financial statements.
              METROVISION OF NORTH AMERICA, INC.

  INTERIM CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

                                      March 31,  March 31,
                                         1997       1998
                                     (Unaudited)(Unaudited)

REVENUES:
 Equity in earnings of York Hannover
  Partnership                           $221,139   $202,459
      Net revenues                      221,139     202,459

OPERATING COSTS AND EXPENSES:
 General and administrative                   --     60,000
 Management fees                          75,000         --
      Total operating expenses            75,000     60,000
      Operating income                   146,139    142,459

OTHER INCOME (EXPENSE):
 Interest expense, net                   (69,677)  (62,302)
 Amortization of deferred revenue         33,285         --
 Realized loss on sale of securities     (66,914)        --
      Total other expense               (103,306)  (62,302)

NET INCOME BEFORE PREFERRED STOCKHOLDER
    DIVIDEND REQUIREMENTS                  42,833    80,157

LESS - PREFERRED STOCK DIVIDEND
REQUIREMENTS                                 $--  $(45,041)

NET INCOME APPLICABLE TO COMMON STOCK     $42,833   $35,116

NET INCOME PER COMMON SHARE                  $.01      $.01
WEIGHTED AVERAGE NUMBER OF SHARES       4,000,000 5,574,275

The accompanying notes to the interim condensed
consolidated financial statements are an integral part of
these consolidated financial statements.

            METROVISION OF NORTH AMERICA, INC.
      INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH
                          FLOWS
                                    March 31   March 31,
                                       1997      1998
                                  (Unaudited) (Unaudited)
CASH FLOWS FROM OPERATING ACTIVITIES:
 Net income                          $42,833    $80,157
 Adjustments to reconcile net income
  to net cash provided by (used in)
  operating activities:
   Realized loss on sale of marketable
    securities                        66,914         --
   Amortization of non-compete
    agreement                        (33,285)        --
   Equity in earnings in excess of
    distributions of York Hannover
    Partnership                      (188,571) (102,459)
 Changes in operating assets and
  liabilities:
   Increase (decrease) in accounts
    payable and other accrued expenses (1,648)   90,802
      Net cash provided by (used in)
       continuing operations         (113,757)   68,500

Discontinued Operations:
  Change in discontinued net
   liabilities                              --  (39,692)
      Net cash (used in)
       discontinued operations              --  (39,692)
      Net cash provided by (used in)
       operating activities           (113,757)   28,808

CASH FLOWS USED FOR INVESTING ACTIVITIES:
 Loans to York Hannover Partnership, net
  of payments received                      49,221       --
 Principal payments on notes to related
  parties                                       --  (25,000)
 Loans to related parties, net of payments
  received                                 (22,728)      - -
 Proceeds from repayment of loans from
  Affiliates                                 10,002       --
 Proceeds from sale of marketable
  securities                                399,198       --
      Net cash provided by (used in)
       investing activities                 435,693 (25,000)
                              
                         (Continued)
                              
             METROVISION OF NORTH AMERICA, INC.
   INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
                              
(Continued)
                                    March 31,   March 31
                                       1997       1998
                                 (Unaudited)  (Unaudited)
CASH FLOWS FROM FINANCING ACTIVITIES:
 Principal payments on Long-Term
  Debt Borrowin                        (94,201)       --
Principal repayments of notes payable (275,537)       --
      Net cash used in financing
       activities                     (369,738)       --

NET INCREASE (DECREASE) IN CASH AND CASH
EQUIVALENTS                            (47,802)     3,808

CASH AND CASH EQUIVALENTS,
 beginning of period                     58,291    11,956
CASH AND CASH EQUIVALENTS, end of period$10,489   $15,764
Supplemental Disclosures of Cash Flow
 Information:
   Cash paid during the year for
    interest                            53,877         --

The accompanying notes to the interim condensed consolidated
financial statements are an integral part of these
consolidated financial statements.

             METROVISION OF NORTH AMERICA, INC.
                              
NOTES TO INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                         (UNAUDITED)
March 31, 1998

NOTE A - BASIS OF PRESENTATION

On  April  1,  1997,  MetroVision  of  North  America,  Inc.
("MetroVision")  consummated a  merger  with  York  Hannover
Pharmaceuticals,  Inc.  ("York  Hannover")  that  has   been
accounted  for  as a reverse acquisition of  MetroVision  by
York  Hannover  under the purchase method of  accounting  as
prescribed  by  APB Opinion 16.  Hereinafter, the  "Company"
refers   to   York  Hannover  and  its  acquired   business,
MetroVision.    Accordingly,   the   historical    financial
statements  of  the Company prior to the  merger  have  been
changed  to  reflect the historical financial statements  of
York  Hannover after giving effect to a recapitalization  of
the   historical  stockholders'  equity  of  York  Hannover.
Therefore,  the three months ended March 31, 1998 historical
period represents the operations of the Company.  The  three
months ended March 31, 1997 historical period represents the
operations of York Hannover.
On November 30, 1997, the Company announced its plans to
discontinue its MetroVision media operations, effective
February 28, 1998.  The Company has shut down the operations
and will not receive any proceeds related to the shut-down
as the remaining assets have been written off.  As a result
of the discontinuance, the related assets, liabilities and
results of operations are segregated in the accompanying
consolidated balance sheets, statements of operations and
cash flows.  Net revenues and operating expenses have been
reclassified for amounts associated with discontinued
operations.

The accompanying unaudited interim condensed consolidated
financial statements have been prepared in accordance with
generally accepted accounting principles for interim
financial information and with the instructions to Form
10QSB and Article 10 of regulation S-X.  Accordingly, they
do not include all of the information and footnotes required
by generally accepted accounting principles for complete
financial statements.  In the opinion of management, all
adjustments (consisting of normal recurring accruals)
considered necessary for a fair presentation have been
included.  Operating results for the
three months ended March 31, 1998 are not necessarily
indicative of the results that may be expected for the year
ended December 31, 1998.

NOTE B - INVESTMENT IN YORK HANNOVER PARTNERSHIP

On  August 1, 1995, York Hannover and Pharmaceuticals,  Inc.
and  United Professional Companies, Inc. ("UPC") formed York
Hannover Partnership (the "Partnership") for the purpose  of
providing institutional pharmacy services, infusion therapy,
third-party   billing,  medical  equipment   and   supplies,
respiratory therapy and other services.  UPC and the Company
have   a   60%   and   40%  interest  in  the   Partnership,
respectively.   The Company's investment in the  Partnership
has   been   accounted  for  under  the  equity  method   of
accounting.

During  the  three months ended March 31, 1998, the  Company
engaged  in  negotiations to sell its 40%  interest  in  the
Partnership   to   an   affiliate  of  United   Professional
Companies, Inc.  There can be no assurance that the proceeds
from the proposed sale will be sufficient to satisfy all  of
the   outstanding  obligations  of  the  Company.    It   is
anticipated  that the closing of the proposed sale  will  be
conditioned upon the approval of the Company's shareholders.
The  proceeds  of  the proposed sale are anticipated  to  be
reduced by the revenues of the Partnership allocable to  the
Company  for the period from January 1, 1998 to the date  of
closing.  It is anticipated that the proceeds from the  sale
will  be  used first to satisfy the note payable and related
accrued interest to National HealthCare Corporation.

Item  2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
         CONDITION AND RESULTS OF OPERATIONS

Results of Operations
                              
 Three months Ended March 31, 1998 Compared to Three months
                    Ended March 31, 1997
                              
On  April  1,  1997,  MetroVision  of  North  America,  Inc.
("MetroVision")  consummated a  merger  with  York  Hannover
Pharmaceuticals,  Inc.  ("York  Hannover")  that  has   been
accounted  for  as a reverse acquisition of  MetroVision  by
York  Hannover  under the purchase method of  accounting  as
prescribed  by  APB Opinion 16.  Hereinafter, the  "Company"
refers   to   York  Hannover  and  its  acquired   business,
MetroVision.    Accordingly,   the   historical    financial
statements  of  the Company prior to the  merger  have  been
changed  to  reflect the historical financial statements  of
York  Hannover after giving effect to a recapitalization  of
the   historical  stockholders'  equity  of  York  Hannover.
Therefore,  the three months ended March 31, 1998 historical
period represents the operations of the Company.  The  three
months ended March 31, 1997 historical period represents the
operations of York Hannover.

The  Company is currently negotiating settlement  agreements
with  various  customers due to the  Company's  decision  to
terminate  its  media operations.  In management's  opinion,
adequate  provision  has been made  for  any  material  loss
resulting from the fulfillment of these service commitments.
However,  events  unknown  at  this  time  related  to   the
termination  of the media operations may subsequently  arise
which could have a material adverse impact on the Company.

Net Revenues.  Net Revenues for the three months ended March
31,  1998, were $202,459 a decrease of 8.4% or $18,680  from
net  revenues of $221,139 for the three months  ended  March
31,  1997.   This  decrease in net revenues  for  the  three
months  ended March 31, 1998 was attributable to a  decrease
in equity in earnings from York Hannover Partnership.

Selling,  General  and  Administrative  Expenses.   Selling,
general  and  administrative expenses for the  three  months
ended March 31, 1998 were $60,000, as compared to $0 for the
three  months  ended  March 31,  1997.   This  increase  was
primarily  attributable  to professional  fees  incurred  in
connection with the operation of the Company.

Management Fees.  Management fees for the three months ended
March  31,  1998,  were $0 as compared to $75,000,  for  the
three  months  ended  March 31,  1997.   This  decrease  was
attributable to the reduction in management fees as a result
of the merger.

Other  Expenses.  Other expenses primarily include  interest
expense on a note payable to National HealthCare Corporation
partially  offset  by  the  amortization  of  a  Non-Compete
Agreement.   Other net expenses for the three  months  ended
March 31, 1998, were $62,302, a decrease of 39.7% or $41,004
from  other expenses of $103,306 for the three months  ended
March 31, 1997.  This decrease was primarily the result of a
loss  on  the  sale of marketable securities in January  and
February  1997  of $66,914 offset by a reduction  in  income
from the amortization of deferred revenue as a result of the
merger.

Liquidity and Sources of Capital

At  March 31, 1998, the Company had negative working capital
of $3,748,299  and  a ratio of current  assets  to  current
liabilities of (.004).  Cash was $15,764 at March  31,  1998
and  $11,956  at  December  31,  1997.  Accumulated  deficit
decreased  $80,157 from $3,540,075 at December 31,  1997  to
$3,459,918 at March 31, 1998.  This decrease was the  result
of the net income for the period ended March 31, 1998.
The  Company's  primary  asset is its  ownership  of  a  40%
interest  in  York  Hannover Partnership  (the  "Partnership
Interest").  For the three months ended March 31, 1998,  the
Company's  equity  in earnings from the Partnership  totaled
$202,459.  The proceeds of the proposed sale are anticipated
to be  reduced by the revenues of the Partnership allocable
to the  Company for the period from January 1, 1998 to  the
closing   date.   In  January  1998,  the  Company  received
distributions  of  $100,000.   The  Company  does  not  have
control   over   distributions   made   by   York   Hannover
Partnership.  All Partnership distributions are  subject  to
the availability of Partnership cash.

The  above discussion and the Company's financial statements
have been presented on the basis that it is a going concern,
which  contemplates  the  realization  of  assets  and   the
satisfaction  of  liabilities  in  the  normal   course   of
business.  The Company's independent auditors have  included
an explanatory  paragraph  in  their  report  on  the  1997
consolidated financial statements stating that  the  factors
discussed   below  raise  a  substantial  doubt  about   the
Company's ability to continue as a going concern.

The Company is not currently generating sufficient cash flow
to fund  its operations and is dependent on other financing
in order to sustain its operations.  Although there can  be
no assurance, the Company believes that, based on currently
proposed plans and assumptions relating to the proposed sale
of its Partnership Interest that proceeds will be sufficient
to satisfy the Company's contemplated cash requirements for
1998. Such  cash  requirements  primarily  relate  to  the
payment of  principal and interest on the outstanding  note
payable to National HealthCare Corporation ("NHC") and other
liabilities owed to unrelated third party creditors.   There
can  be  no assurance, however, that the  Company  will  be
successful in its new business endeavors or able to generate
revenues or ever achieve profitable operations.  The Company
has  outstanding a $1,950,000 promissory note payable to NHC
that  became  due on December 31, 1997 and is  currently  in
default  and  payable on demand.  Accrued  interest  in  the
promissory  note  is $223,642 as of March  31,  1998.
The Company  currently  does  not have the  financial
resources necessary  to  meet its payment obligation other
than  from Partnership  distributions or proceeds from the
anticipated sale  of the 40% interest in York Hannover
Partnership.   In the  event  the  Company  is  unable  to
meet  its  payment obligation  and  the  promissory note is
not  re-negotiated, NHC, as a secured creditor, has the
right to take possession of or  otherwise  sell the interest
in the  Partnership  in satisfaction  of  the  indebtedness
and  may  seek  recourse against  the  Company's  other
assets,  if  necessary.   The Company also has outstanding a
$571,957 working capital note payable  to  Lenox
Healthcare, Inc. (an  affiliate  of  the Company) that
becomes due in May of 1998.

During  the  three months ended March 31, 1998, the  Company
engaged  in  negotiations to sell its 40%  interest  in  the
Partnership   to   an   affiliate  of  United   Professional
Companies, Inc. ("UPC").  There can be no assurance that the
proceeds  from  the  proposed sale  will  be  sufficient  to
satisfy  all of the outstanding obligations of the  Company.
UPC currently has a 60% interest in the Partnership.  It  is
anticipated  that the closing of the proposed sale  will  be
conditioned upon the approval of the Company's shareholders.
The  proceeds  of  the proposed sale are anticipated  to  be
reduced by the revenues of the Partnership allocable to  the
Company  for the period from January 1, 1998 to the  closing
date.   It  is anticipated that the proceeds from  the  sale
will  be  used first to satisfy the note payable and related
accrued interest to NHC.

Additionally, during the three months ended March 31,  1998,
the majority holders of the 5% Series A Preferred Stock have
asserted certain claims against the Company which could have
a material  adverse  impact  on  the  Company's  financial
position.   Although  management  does  not  believe   these
assertions represent obligations of the Company as of  March
31,   1998,   management  is  currently   discussing   these
assertions  with the preferred shareholders  in  conjunction
with   the   structuring  of  the  proposed  sale   of   the
Partnership.  Management believes that these assertions will
be resolved during 1998 through ongoing discussions with the
preferred  shareholders  but  is  unable  to  determine  the
ultimate outcome of the ongoing discussions.

Subsequent  to  the anticipated sale of the Partnership  and
subject to shareholder approval, management intends to  seek
business  combination opportunities with other  entities  in
1998.   However,  no such opportunities are currently  known
and  there can be no assurance that the Company will be able
to locate such an opportunity in 1998.

The Company has not identified any potential sources of debt
or equity financing and there can be no assurance that  the
Company will be able to obtain additional financing  if  and
when  needed  or that, if available, financing  will  be  on
terms  acceptable to the Company.  Furthermore, the  results
of these  matters  cannot  be predicted  and  there  is  no
assurance that the Company will continue in existence.

In  the  event the Company's plans change or its assumptions
change  or prove inaccurate or proceeds of the sale  of  the
Partnership Interest prove to be insufficient to payoff  the
Company's debt and operating liabilities, the Company may be
required to seek additional financing.  The Company  has  no
current   arrangements  with  respect  to  or   sources   of
additional financing other than the current working  capital
line of credit or the sale of its Partnership Interest,  and
there  can  be no assurance that financing will be available
to the Company on commercially reasonable terms, if at all.
Any inability to obtain additional financing could  have  a
material  adverse effect on the Company, including  possibly
requiring the Company to cease its operations.

Year 2000 Compliance

The  Company  is currently in the process of evaluating  its
information   technology  infrastructure   for   Year   2000
Compliance.   The Company does not expect that the  cost  to
modify its information technology infrastructure to be  Year
2000  compliant will be material to its financial  condition
or  results  of operations.  The Company does not anticipate
any material disruption in its operations as a result of any
failure to be in compliance.  However, the Company currently
does  not  have  any information concerning  the  Year  2000
Compliance  status of York Hannover Partnership's customers,
suppliers and third party payors.  In the event that any  of
York Hannover Partnership's significant suppliers, customers
or third party payors do not successfully and timely achieve
Year 2000 Compliance, the Company's business and operations
could be adversely affected.

Item   3.  QUALITATIVE   AND   QUANTITATIVE   INFORMATION
           ABOUT MARKET RISK
Not applicable.

             METROVISION OF NORTH AMERICA, INC.
                 PART II - OTHER INFORMATION
                              
Item 6. EXHIBITS AND REPORTS ON FORM 8-K
(a)  Exhibits. None.
(b)  No  Reports  on Form 8-K were filed during  the  three
     months ended March 31, 1998.

             METROVISION OF NORTH AMERICA, INC.
                         SIGNATURES

Pursuant to the requirements of the Securities Exchange  Act
of 1934, the registrant has duly caused this report  to  be
signed on  its  behalf  by the undersigned  thereunto  duly
authorized.

METROVISION OF NORTH AMERICA, INC.
(Registrant)

Date:  May 15, 1998         /s/Thomas M. Clarke
                         Thomas M. Clarke, President
                           (Duly authorized Officer)

Date: May 15, 1998          /s/ David M. Fancher
                              David M. Fancher
                           Chief Financial Officer
                 (Principal Financial & Accounting Officer)

             METROVISION OF NORTH AMERICA, INC.
                         SIGNATURES

Pursuant to the requirements of the Securities Exchange  Act
of 1934, the registrant has duly caused this report  to  be
signed on  its  behalf  by the undersigned  thereunto  duly
authorized.

METROVISION OF NORTH AMERICA, INC.
(Registrant)

Date:  May 15, 1998
                         Thomas M. Clarke, President
                           (Duly authorized Officer)

Date: May 15, 1998
                              David M. Fancher
                           Chief Financial Officer
                 (Principal Financial & Accounting Officer)